Clinical trial
Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology…
NCT00197951 · Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Other · Completed
Key facts
| NCT number | NCT00197951 |
|---|---|
| Title | Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology Associated to Alcoholism |
| Official title | Clinical Trial With Ziprasidone for the Treatment of Psychiatric Pathology, Not Being a Severe Mental Disorder, Associated to Alcohol Dependence Disorder. |
| Lead sponsor | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Depression, Anger, Anxiety, Alcoholism |
| Intervention type | Drug |
| Interventions | Treatment of psychiatric symptoms associated to alcoholism |
| Enrollment | 60 |
| Start date | Oct 1, 2004 |
| Completion | Apr 1, 2007 |
| First posted | Sep 20, 2005 |
| Last update posted | Apr 23, 2007 |
| Countries | Spain |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: